Stepwise prolongation of overall survival from first to third generation EGFR-TKIs for <i>EGFR</i> mutation-positive non-small-cell lung cancer: the Tokushukai REAl-world Data project (TREAD 01)Kiyoaki Uryu, Hironobu Minami, Megu Ohtaki et al.|Japanese Journal of Clinical Oncology|2023Cited by 6
Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1Kiyoaki Uryu, Hironobu Minami, Yoshinori Imamura et al.|Cancer Chemotherapy and Pharmacology|2024Cited by 2
Public assistance and survival equality in patients with <i>EGFR</i> mutation-positive lung cancerKiyoaki Uryu, Hironobu Minami, Yoshinori Imamura et al.|Japanese Journal of Clinical Oncology|2024Cited by 1